abstract |
The application provides (a) a compound of pyrimidine sulfonamide of formula (I) or (b) a pharmaceutically acceptable salt thereof, a crystalline form of the compound, a method for obtaining the compound, and a drug intermediate used in the preparation of the compound and pharmaceutical compositions containing said compounds. The compounds are useful in the treatment of diseases/disorders in which modulation of chemokine receptor activity is beneficial. |